Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Get your questions posted!
View:
Post by ronrydell on Jun 20, 2022 2:36pm

Get your questions posted!

r U listing now everyone?
Comment by chrispi on Jun 20, 2022 2:49pm
r U listening now everyone? Yes sir :) Replay of webinar will also be put on the Bioasis website for 4 weeks. Here we come folks ... gonna be an interesting next 6 months from here with Nasdaq listing (the big one, not the OTC) and other initiatives! Finally gonna get the US exposure to the big boyz (and girlz), funds, analysts, and retail.  
Comment by ronrydell on Jun 20, 2022 2:59pm
Exposure to the world will be great.....I hope people start buying as this stock is "ultra cheap". (JD where are you on this)
Comment by G1945V on Jun 20, 2022 3:07pm
Nothing said where the $6 Mill is coming from for the 2, Phase 2 Clinical Trials of EGFI-48.  And the XB3 platform is not part of the Phase 2 studies seeing that both RGFI-48 assets are BBB penetrable.  That's for another time down the road. G1945V
Comment by MineDigger on Jun 20, 2022 4:21pm
I onl hear the last 10mins or so, that "$6m" I see mentioned, is that the cost of the Phase II, and/or does it include enough to keep the rest of the Bioasis ship afloat meantime, or something else? Was there no pdf and/or slideshow to go with this?
Comment by narmac on Jun 20, 2022 5:22pm
Can you say,,,,,,toooo dahhhhh moooon,,,,,nasdaq,,,,,and also several entities in discussion around our 001 platform!!!,,,,,the landscape is changing,,,,,,and it can change with the stroke of a pen now,,,,,and the new developments are clearly an advantage to us more than Cresence imo,,,,,,,and all the while we wait on clinical trial/s with our xB3 partners. I like it!!,,,,minimal cost for a huge ...more  
Comment by prophetoffactz on Jun 20, 2022 3:05pm
Interesting that BTI still appears to be 2-3 years from filing an IND for xB3 and that given BTI will be doing a small staged financing on the way to $6 million it doesn't appear as though there is much if any significant money coming in from partner mllestones or licensing of xB3 any time soon despite the timelines since the deals were announced. Difficult market conditions were mentioned ...more  
Comment by Finallytherock on Jun 20, 2022 4:19pm
it's scary how cluless you appear to be
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities